P

Piomic

Piomic, a Swiss medtech startup spun out of ETH Zurich, develops physical stimulation therapies for deep tissue regeneration. Their lead product, the COMS One Therapy System, is a portable, non-invasive device for treating non-healing wounds. This $25 million growth round will fund clinical trials, US market approval filing, and expansion into new applications.

Total raised
Undisclosed
tracked to date
Latest round
Growth
Sep 18, 2026
Known investors
6
led by Swisscanto

Is this your company?

Claim this profile to get matched with investors who fund Health startups in Switzerland.

Claim this profile →

🏆 Featured in Datapile’s Q3 2026 Switzerland Funding Report

Read the Q3 2026 Switzerland report →
Add this badge to your site
<a href="https://datapile.co/reports/q3-2026-switzerland-startup-funding" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:9px 16px;border-radius:9999px;background:#0B1224;color:#ffffff;font:600 13px/1.2 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,sans-serif;text-decoration:none;border:1px solid #7C5CFF"><span style="display:inline-block;width:11px;height:11px;border-radius:3px;background:#7C5CFF"></span>Featured in Datapile&rsquo;s Q3 2026 Switzerland Funding Report</a>

Funding history

  1. 1
    $25 millionGrowthSep 18, 2026

    Led by Swisscanto

    Announcement ↗

Investors in Piomic

Backers from this company's tracked funding rounds.

  • SSwisscantoLead investorVC firm
  • DDiabetes Venture FundVC firm
  • ZZürcher KantonalbankVC firm
  • VVerve VenturesVC firm
  • SSky StiftungVC firm
  • NN&V CapitalVC firm

Piomic in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile